Terug
Dagbereik
€ 11,63
€ 12,19
52-Weeksbereik
€ 9,82
€ 20,06
Volume
1.263.901
50D / 200D Gem.
€ 12,55
/
€ 13,35
Vorige Slotkoers
€ 11,81
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -9,9 | 0,4 |
| P/B | 4,0 | 2,9 |
| ROE % | -38,9 | 3,8 |
| Net Margin % | -20,8 | 3,9 |
| Rev Growth 5Y % | 5,2 | 10,0 |
| D/E | 0,9 | 0,2 |
Koersdoel Analisten
Hold
€ 33,50
+183.4%
Low: € 20,00
High: € 47,00
Forward WPA
-€ 1,51
Omzet Sch.
690 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 4,79
€ 4,49 – € 5,35
|
1,8 B | 1 |
| FY2029 |
€ 2,45
€ 2,30 – € 2,73
|
1,5 B | 1 |
| FY2028 |
-€ 0,42
-€ 0,50 – -€ 0,37
|
920 M | 3 |
Belangrijkste Punten
Revenue grew 5,20% annually over 5 years — modest growth
Negative free cash flow of -75,68M
PEG of 0,49 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3,08%
Capital efficient — spends only 4,07% of revenue on capex
Groei
Revenue Growth (5Y)
5,20%
Revenue (1Y)8,28%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-38,89%
ROIC-18,30%
Net Margin-20,79%
Op. Margin-23,47%
Veiligheid
Debt / Equity
0,85
Current Ratio2,90
Interest Coverage0,00
Waardering
P/E Ratio
-9,87
P/B Ratio3,95
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8,28% | Revenue Growth (3Y) | 13,43% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 5,20% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 655,35M | Net Income (TTM) | -136,23M |
| ROE | -38,89% | ROA | -16,94% |
| Gross Margin | 74,54% | Operating Margin | -23,47% |
| Net Margin | -20,79% | Free Cash Flow (TTM) | -75,68M |
| ROIC | -18,30% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,85 | Current Ratio | 2,90 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -9,87 | P/B Ratio | 3,95 |
| P/S Ratio | 2,05 | PEG Ratio | 0,49 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,35B | Enterprise Value | 1,53B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 655,35M | 605,22M | 509,34M | 537,84M | 535,03M |
| Net Income | -136,23M | -168,63M | -207,04M | -92,53M | -58,35M |
| EPS (Diluted) | -1,22 | -1,56 | -1,95 | -0,88 | -0,56 |
| Gross Profit | 488,47M | 468,04M | 381,06M | 422,97M | 420,15M |
| Operating Income | -153,80M | -170,50M | -232,87M | -89,52M | -44,33M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 804,33M | 1,24B | 1,15B | 1,19B | 1,14B |
| Total Liabilities | 463,86M | 880,61M | 783,63M | 750,48M | 729,00M |
| Shareholders' Equity | 340,47M | 360,18M | 362,50M | 441,17M | 410,49M |
| Total Debt | 290,00M | 683,35M | 596,24M | 584,27M | 581,90M |
| Cash & Equivalents | 103,39M | 163,77M | 240,82M | 115,33M | 209,61M |
| Current Assets | 646,73M | 1,11B | 1,03B | 1,11B | 1,07B |
| Current Liabilities | 223,23M | 756,38M | 179,12M | 158,78M | 142,60M |